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Abstract
Dissemination of Bacillus anthracis from the respiratory mucosa is a critical step in the establishment of inhalational anthrax.
Recent in vitro and in vivo studies indicated that this organism was able to penetrate the lung epithelium by directly
entering into epithelial cells of the lung; however the molecular details of B. anthracis breaching the epithelium were
lacking. Here, using a combination of pharmacological inhibitors, dominant negative mutants, and colocalization
experiments, we demonstrated that internalization of spores by epithelial cells was actin-dependent and was mediated by
the Rho-family GTPase Cdc42 but not RhoA or Rac1. Phosphatidylinositol 3-kinase (PI3K) activity was also required as
indicated by the inhibitory effects of PI3K inhibitors, wortmannin and LY294002, and a PI3K dominant negative (DN) mutant
Dp85a. In addition, spore entry into epithelial cells (but not into macrophages) required the activity of Src as indicated by
the inhibitory effect of Src family kinase (SFK) inhibitors, PP2 and SU6656, and specific siRNA knockdown of Src. Enrichment
of PI3K and F-actin around spore attachment sites was observed and was significantly reduced by treatment with SFK and
PI3K inhibitors, respectively. Moreover, B. anthracis translocation through cultured lung epithelial cells was significantly
impaired by SFK inhibitors, suggesting that this signaling pathway is important for bacterial dissemination. The effect of the
inhibitor on dissemination in vivo was then evaluated. SU6656 treatment of mice significantly reduced B. anthracis
dissemination from the lung to distal organs and prolonged the median survival time of mice compared to the untreated
control group. Together these results described a signaling pathway specifically required for spore entry into epithelial cells
and provided evidence suggesting that this pathway is important for dissemination and virulence in vivo.
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Introduction
Inhalational anthrax is a life-threatening infection initiated by
pulmonary exposure to Bacillus anthracis spores. The pathogen then
disseminates away from the lung to establish a systemic infection.
The systemic spread is thought to come from hematogenous
sources; however, how B. anthracis disseminates from the lung, the
initial entry site, to the blood remains poorly understood.
Although B. anthracis is primarily an extracellular pathogen,
studies from multiple groups have indicated that an intracellular
stage is necessary for the pathogen to breach the lung epithelial
barrier [1,2,3,4]. Mice can be protected by immunization with
inactivated spores. The protection was found to be from cellular
rather than humoral immunity, further highlighting the impor-
tance of an intracellular stage in the establishment of anthrax
infections [5]. In the lung, spores encounter three major types of
cells, epithelial cells in the alveoli and small airway, resident
alveolar macrophages (AMs), and lung dendritic cells (LDCs). AMs
and LDCs have been indicated to play roles in the dissemination
process by first engulfing spores and then carrying them to
regional lymph nodes [2,3]. Spores germinate inside the
phagocytes, replicate and eventually escape from them via an
undefined mechanism. Another strategy often used by pathogens
to breach mucosal barriers is by entering into non-phagocytic host
cells and then escaping from them. Recent studies suggested that
B. anthracis spores may use this strategy as well [1,4]. Spores of B.
anthracis can be internalized by polarized A549 cells (human
alveolar type II-like epithelial cells) and primary human small
airway epithelial cells (hSAECs) [1,6]. In addition, substantial
amounts of spores were found inside epithelial cells of the lung in
mice within hours of inoculation [4], indicating that spore entry
into lung epithelial cells is relevant in vivo. Furthermore, B. anthracis
can cross a barrier of lung epithelial cells in the absence of
phagocytes and without compromising the barrier integrity [1].
Spores and vegetative bacilli are also able to survive inside lung
epithelial cells [1], in contrast to the finding in macrophages
[7,8,9]. Thus spore entry into lung epithelial cells appears to be an
important early event in the development of inhalational anthrax.
Spore-lung epithelium interactions have also been shown to
influence host immune responses. Using a human lung slice model,
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protein kinase signaling pathways and increases in the cytokines
levels (e.g., IL-6, TNF-a, IL8, MIP-1a/b, and MCP-1) upon
exposure to spores. Lung epithelial cells as well as alveolar
macrophages were the main sources for the increased cytokines
and chemokines [10]. A recent report by Evans et al. showed that
mice treated with bacterial lysates developed an innate immunity
to infections by B. anthracis spores. Interestingly, lung epithelial
cells not macrophages or neutrophils were responsible for the
induced resistance [11]. These results further underscored the
importance of spore-epithelium interactions in the pathogenesis of
B. anthracis. However, prior to this study little information was
available regarding the molecular mechanism of spore-epithelium
interactions, what factors mediate spore entry into epithelial cells
or the biological consequence of disrupting the entry process.
We previously showed that spore germination was not required
for internalization by non-phagocytic cells, and that spores of B.
subtilis were internalized by host cells at a significantly lower
frequency than that of B. anthracis spores [1,6]. These results
indicated that specific components on B. anthracis spores were
necessary and sufficient to induce spore entry into non-phagocytic
cells. Therefore, in this study we sought to investigate the entry
mechanism of wild-type spores by elucidating the cellular
components and signaling molecules in epithelial cells required
for the internalization process. Using a combination of specific
pharmacological inhibitors, dominant negative mutants, colocali-
zation experiments and specific siRNA knockdown, a signaling
pathway responsible for mediating the internalization of spores by
epithelial cells was uncovered. The importance of this signaling
pathway in bacterial dissemination in vitro and in vivo was also
investigated.
Results
B. anthracis spore internalization by epithelial cells is
actin-dependent
We first examined if spore internalization by epithelial cells was
dependent on the actin cytoskeleton. Cytochalasin D, an inhibitor
of actin polymerization, inhibited spore uptake by A549 cells in a
dose-dependent manner (Fig. 1, A). Uptake of spores was nearly
abolished in the presence of 10 mM cytochalasin D. Similar results
were observed in HeLa cells and hSAECs (Fig. 1, B and C). Cell
viability was not affected by cytochalasin D at the concentrations
used, as assessed by trypan blue exclusion. Nor was spore viability
affected, as determined by plating and colony counts.
We further investigated if spores colocalized with F-actin during
entry by fluorescence microscopy. After 30 minutes of incubation,
approximately 17.4% of the total attached spores were seen
surrounded by enriched F-actin staining (SEM =1.9%, n=6
independent assays) (Fig. 1, D – G), suggesting that there was local
activation of actin polymerization or reorganization at these sites.
In general, the ratio of internalization spores vs. attached spores
under our assay conditions is approximately 1:10–1:5. The
percentage of attached spores with enriched F-actin is consistent
with this ratio. We determined that spores did not emit green
fluorescence by themselves by examining spores attached to
coverslips in the absence of cells. To rule out the possibility that
the colocalization was due to preferential attachment of spores to
pre-existing actin-rich patches, we performed the experiment in
the presence of cytochalasin D. Colocalization of spores with F-
actin was significantly reduced (by ,61%) in cytochalasin D-
treated cells (***, p,0.001 compared to no inhibitor), suggesting
that there was active polymerization of F-actin at these spore
attachment sites (Fig. 1, G). Cytochalasin D did not completely
abolish F-actin enrichment around spores. This could be due to
the possibility that cytochalasin D prevented short actin filaments
from polymerization. However, these short actin filaments could
still be recruited to the spore attachment sites, although they were
not able to drive the internalization process [12]. Together the
above results indicated that spore internalization by epithelial cells
required actin polymerization.
The Rho-family GTPase Cdc42 is required for spore
uptake
The Rho family of small GTPases regulates the polymerization
and reorganization of the actin cytoskeleton. RhoA, Rac1 and
Cdc42 are the three major Rho GTPases. RhoA mainly mediates
stress fiber formation, Rac1 lamellipodia and filopodia, and Cdc42
filopodia [13]. We investigated which of the three Rho GTPases
was responsible for spore internalization by epithelial cells.
T19NRhoA, T17NRac1 and T17NCdc42 are mutants of these
GTPases that lack the ability to adopt the active GTP-bound form,
but maintain the ability to bind guanine nucleotide exchange
factors (GEFs). They are widely used as dominant negative (DN)
mutants for the respective proteins [14]. HeLa cells were
transfected with plasmids expressing either HA-tagged
T19NRhoA, T17NRac1, T17NCdc42 or the vector control,
respectively. The expression of the three DN mutant proteins in
transfected cells was confirmed by western blot analysis of cell
lysates 24 hours post-transfection (Fig. 1, H). Spore internalization
was significantly reduced in cells transfected with T17NCdc42, but
not in cells transfected with T19NRhoA or T17NRac1 (Fig. 1, I).
None of the three DN mutants affected spore adherence to cells
(Fig. 1, J), as expected. Transfection efficiency was approximately
80%, as determined by transfecting cells with a GFP expressing
plasmid. The relatively moderate inhibition by DN Cdc42 mutant
compared to that by cytochalasin D treatment could be due to
incomplete transfection and/or incomplete inhibition of the
endogenous Cdc42 activity. Similar results were observed in
A549 cells transfected with the respective plasmids, i.e., approx-
imately 35% decreases in spore internalization were only observed
in A549 cells transfected with T17NCdc42 but not in cells
transfected with the other two DN mutants (data not shown).
Transfection did not affect cell viability, assessed by trypan blue
exclusion. These results indicate that Cdc42, but not Rac1 or
RhoA, regulates actin polymerization during spore uptake.
Internalization of B. anthracis spores by epithelial cells
requires phosphatidylinositol 3-kinase (PI3K)
PI3K is required for the internalization of a number of bacteria
by host non-phagocytic cells. We tested the effect of different
concentrations (0–50 nM) of wortmannin, a specific PI3K
inhibitor, on spore internalization by A549 cells. A dose-
dependent inhibition was observed (Fig. 2, A). The IC50 was
calculated to be ,6–10 nM (non-linear regression curve fit,
GraphPad Prism software), consistent with the reported IC50 of
wortmannin for PI3K [15]. The effect was not specific to A549
cells. Spore uptake by HeLa cells was also dramatically reduced
(,80%) by wortmannin (100 nM) (Fig. S1, A). LY294002 inhibits
PI3K enzymatic activities by a mechanism distinct from that of
wortmannin [15]. The effect of LY294002 was also tested.
LY294002 had a similar effect on spore internalization as that of
wortmannin, ,60% reduction on spore internalization by A549
cells (Fig. 2, B) and ,70% by HeLa cells at the concentration used
(Fig. S1, A). As expected, no significant effect on spore adherence
to A549 (Fig. 2, C) or HeLa cells (Fig. S1, B) by either inhibitor
was observed. The fact that both inhibitors caused significant
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activity is required for spore internalization. Neither wortmannin
nor LY294002 affected the viability of cells or spores.
As PI3Ks are also involved in other cellular processes such as
intracellular vesicle trafficking, we tested if the reduction of
intracellular bacteria in inhibitor treated cells was due to alterations
in some intracellular processes post spore entry. Spores were
allowed to be taken up by A549 cells in the absence of the inhibitor
and then treated with wortmannin. No significant difference in the
number of intracellular bacteria was observed between wortman-
Figure 1. B. anthracis spore internalization by epithelial cells requires actin polymerization mediated by Cdc42. A – C, the effect of
cytochalasin D on spore internalization by A549 (A), HeLa (B) and hSAECs (C). Cells were pretreated with different concentrations (0.01 – 10 mM for
A549 cells, 1 and 10 mM for HeLa and hSAECs, respectively) of cytochalasin D (Cyto D) or the solvent control (Ctrl) for 1 hr and then performed
fluorescent microscopic examination as described in Materials and Methods. Relative internalization (%) is the ratio of intracellular spores vs. total
adhered spores, normalized to the solvent control. The results are the mean 6 SEM from at least two independent experiments. D – F, representative
images of colocalization of F-actin with spores. A549 cells were incubated with Texas-Red labeled spores and then stained with phalloidin-Alexa Fluor
488. G, colocalization of F-actin with spores is inhibited by Cyto D. Cyto D (10 mM) was included in the colocalization examination as described in
Materials and Methods. The percentage of spores with enriched F-actin staining vs. total attached spores is denoted as %Colocalization. The results
shown are combined from five independent experiments. ***, p,0.0001, t test. Scale bars represent 5 mm. H – J, Cdc42 is the primary Rho-family
GTPase required for spore uptake. A549 cells were transfected with pcDNA3.1(+) vector control (Ctrl), HA-T19NRhoA (T19NRhoA), HA-T17NRac1
(T17NRac1) or HA-T17NCdc42 (T17NCdc42). The expression of the transfected constructs was verified using western blot analysis 24 hr post
transfection (H). Dominant negative GTPases were detected by anti-HA antibodies and secondary antibodies as described in Materials and Methods.
The actin level was used as a loading control. Spore uptake by (I) and adherence to (J) transfected cells were determined by gentamicin protection
assays 24 hr post transfection as described in Materials and Methods. Relative internalization (%) is the ratio of intracellular spores vs. total spores
added, normalized to the solvent control. Relative association (%) is the ratio of associated spores (extracellular adhered + intracellular) vs. total
spores added, normalized to the solvent control. The results shown are the mean 6 SEM, combined from three independent experiments.
**, p=0.0018, t test.
doi:10.1371/journal.pone.0011665.g001
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that the reduction of intracellular bacteria caused by the PI3K
inhibitors was due to impaired spore entry.
There are three classes of PI3Ks, among which class I PI3Ks
are involved in regulating the actin cytoskeleton. This class is
further divided into two sub-groups, IA and IB. Class IA enzymes
are ubiquitously expressed and are made up of a 110 kDa
catalytic subunit (p110) and an adaptor/regulatory subunit, the
most abundant of which in mammalian cells is p85a [16]. Class
IB PI3K is primarily expressed in white blood cells. We tested if
spore entry into epithelial cells was mediated by a class IA PI3K.
A dominant negative construct for class IA PI3Ks, Dp85a,w a s
employed for this purpose. This mutant lacks the binding site for
the catalytic p110 subunit and therefore cannot recruit p110
upon activation [17]. Plasmid constructs of HA-tagged Dp85a,
wild-type p85a,o rS R a (vector) were transfected into A549 and
Figure 2. B. anthracis spore internalization by epithelial cells requires PI3K activity. A – C, spore internalization by A549 cells is inhibited by
PI3K inhibitors, wortmannin (WM) and LY294002 (LY). Cells were pre-incubated with 0–50 nM WM, 50 mM LY, or the solvent control (Ctrl) for 1 hr and
infected with spores in the presence of the inhibitor. Intracellular and extracellular spores were determined by gentamicin protection assay (A) and
fluorescence microscopic examination (B and C). Relative internalization (%) is as described in the legend for Fig. 1. Relative adherence (%) is the ratio
of extracellular bound spores vs. total fields counted, normalized to the control. The gentamicin protection result is the mean 6 SEM from a
representative experiment. The fluorescence microscopic results are combined from at least two independent experiments. D – F, spore
internalization by A549 cells is inhibited by dominant negative p85. A549 cells were transfected with SRa vector control (Ctrl), HA-Dp85a (Dp85a) and
HA-p85a (p85a). The expression of HA-Dp85a and HA-p85a in transfected cells was analyzed by western blot using anti-HA antibodies and
appropriate secondary antibodies 24 hr post transfection (D). Spore internalization by (E) and association with (F) transfected cells were determined
using gentamicin protection assays 24 hr post transfection. The results are the mean 6 SEM, combined from three independent experiments. ***,
p,0.001; **, p,0.01, t test. G – I, PI3K is rapidly recruited and activated at spore entry sites. A549 cells were transfected with Akt-PH-GFP, incubated
with Texas Red-labeled spores for 8 min and processed for confocal examination. Representative images are shown. Arrows indicate the spore
attachment sites where Akt-PH-GFP was recruited. Scale bars represent 5 mm. J, Quantitation of Akt-PH-GFP recruitment at spore attachment sites in
the absence (Ctrl) or presence of the PI3K inhibitors. WM (100 nM) or LY (50 mM) was included in the colocalization assay. The percentage of spores
surrounded with enhanced green fluorescence vs. total attached spores is denoted as %Recruitment. The results shown are combined from four
independent experiments. ***, p,0.001, t test.
doi:10.1371/journal.pone.0011665.g002
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mately 40% for A549 cells and 80% for HeLa cells, estimated by
transfecting cells with a GFP-expressing plasmid. Expression of
HA-Dp85a and HA-p85a in transfected cells was confirmed by
western blot analysis of cell lysates 24 hours post-transfection
using anti-HA antibodies (Fig. 2, D and Fig. S1, C). The mutant
migrated slightly faster than wild-type p85a since it lacked the
p110 binding site and had a smaller molecular weight. Analysis of
spore internalization showed that expression of Dp85a signifi-
cantly decreased the spore internalization frequency (by ,45%)
in both A549 (Fig. 2, E, **, p,0.01) and HeLa cells (Fig. S1, D,
***, p,0.001) when compared to cells transfected with the vector
control. The decrease (,45%) in spore internalization caused by
Dp85a expression was less dramatic than that by the two PI3K
inhibitors. This was likely due to the moderate transfection
efficiency, competition between Dp85a and the endogenous
p85a, and the presence of other regulatory subunits of PI3Ks,
which could potentially compensate for p85a. Over expression of
exogenous wide-type p85a did not increase spore internalization,
possibly because the amount of endogenous adaptors was
sufficient to mediate spore internalization (Fig. 2, E and Fig.
S1, D). Spore adherence to cells was not affected by Dp85a
expression (Fig. 2, F and Fig. S1, E). Neither HA-Dp85a nor HA-
p85a expression affected cell viability as determined by trypan
blue exclusion. Altogether, the above results indicate that
internalization of B. anthracis spores by epithelial cells requires
PI3K activity, primarily the activity of a class IA PI3K.
Upon activation, class I PI3Ks phosphorylate PtdIns(4,5)P2 to
PtdIns(3,4,5)P3, which binds to the PH domain of downstream
effectors such as the serine/threonine protein kinase Akt/PKB [18].
In order to examine PI3K recruitment and activation, a construct
containing the Akt-PH domain fused to a GFP gene (Akt-PH-GFP)
was used as a molecular probe for the PI3K product PtdIns(3,4,5)P3
[19]. A549 cells transfected with the Akt-PH-GFP construct were
serum-starved and then incubated with Texas Red-labeledB.anthracis
spores. Approximately 28.0% of attached spores recruited Akt-PH-
GFP within minutes of incubation (SEM =1.6%, n=6 independent
assays) (Fig. 2, G – J). Also, significantly less Akt-PH-GFP recruitment
was observed (***, p,0.001 compared to no inhibitor) in cells treated
with wortmannin or LY294002 (Fig. 2, J), suggesting that the
recruitment was due to PI3K activation. The incomplete inhibition of
Akt-PH recruitment by the inhibitors has been previously reported
[20,21]. Together, theseresultsfurther confirm that a classIA PI3K is
recruited and activated during spore internalization.
c-Src, a member of the Src family protein tyrosine
kinases, is required for the internalization of B. anthracis
spores by epithelial cells
To determine if Src family protein tyrosine kinase (SFK) activity
was required for spore internalization by epithelial cells, PP2, a
specific SFK inhibitor and its negative control compound, PP3,
were used to treat A549 cells. Spore internalization was inhibited
by PP2 (,70%) but not by PP3 (Fig. 3, A). Spore adherence to
A549 cells was not affected by either PP2 or PP3 (Fig. 3, B).
Figure 3. Spore internalization by epithelial cells requires the protein tyrosine kinase Src. A and B, spore internalization by A549 cells is
inhibited by PP2 but not PP3. Cells were pre-treated with PP2 (10 mM), PP3 (10 mM) or solvent control (Ctrl) for 1 hr and then incubated with labeled
7702 spores in the presence of the inhibitors. Intracellular and extracellular spores were quantified by fluorescence microscopic examination. Relative
internalization (A) and relative adherence (B) were calculated as the number of intracellular and extracellular adhered spores vs. total fields counted,
respectively, and were normalized to the control. The results are the mean 6 SEM from at least 2 independent assays. C – G, knockdown of c-Src by
siRNA significantly reduces spore internalization. A549 cells were transfected with 50 nM siRNA for Src (Src KD), Yes (Yes KD), Fyn (Fyn KD) or control
siRNA (Ctrl). Spore internalization (C) and adherence (D) were determined by gentamicin protection assays 48 hr post transfection. The results were
from three independent experiments. ***, p,0.001; *, p=0.0165, Student’s t test, normalized to the control. The knockdown of protein levels in
transfected cells was determined by western blot using specific antibodies against Src (E), Yes (F) and Fyn (G).
doi:10.1371/journal.pone.0011665.g003
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PP2, was also tested. SU6656 at a concentration of 50 mM
significantly inhibited spore entry into A549 cells by approximately
70% (data not shown). None of the compounds affected the
viability of cells or spores. Next we tested the effect of PP2 on spore
uptake by epithelial cells of different origin and spore phagocytosis
by macrophages. PP2 inhibited spore uptake by HeLa, hSAECS,
and MLE15 (a murine lung epithelial cell line) cells, suggesting
that SFK activity is required for spore internalization by epithelial
cells from different origins. In contrast the same concentration of
PP2 did not affect spore phagocytosis by RAW264.7 macrophages
or murine primary peritoneal macrophages (Fig. S2, A), suggesting
that SFK activity is specifically required for spore entry into
epithelial cells. It was recently reported that PI3K activity was
involved in spore phagocytosis by macrophages [22]. We tested
the effect of LY294002 and found that spore phagocytosis in fact
was inhibited by LY294002 (Fig. S2, B), consistent with the
previous report [22].
Of the nine Src family tyrosine kinases, c-Src, c-Yes and Fyn
are ubiquitously expressed, while others are primarily expressed
in cells of the hematopoietic lineage [23]. Therefore, these three
kinases are likely candidates involved in spore internalization. We
first tested murine embryonic fibroblasts (MEFs) from src-/-yes-/-
fyn-/- triple knockout mice (obtained from ATCC). Spore
internalization by the triple knockout MEFs was ,80% lower
compared to that by wild type MEFs (data not shown). To
determine which one of the three kinases was required for spore
internalization by epithelial cells, A549 cells were transfected with
specific siRNAs for c-Src, c-Yes and Fyn. Analysis of spore
internalization in cells transfected with the different siRNAs
indicated that knockdown of c-Src decreased spore internaliza-
tion by approximately 60% (***, p,0.001 compared to the
control), whereas knockdown of c-Yes or Fyn had no or only
marginal inhibitory effect (Fig. 3, C). Spore adherence was not
affected by knockdown of any of the three kinases (Fig. 3, D).
Specific knockdown of the targeted protein kinase was confirmed
using western blot analysis (Fig. 3, E – G). These results indicate
that c-Src is the primary SFK involved in spore uptake by
epithelial cells.
Src and PI3K function in the same signaling pathway to
mediate spore internalization
To understand the connection between the different signaling
molecules elucidated above, we first investigated whether PI3K
and c-Src were required for actin polymerization during spore
entry. F-actin enrichment around spore attachment sites was
significantly reduced in cells treated with the PI3K inhibitors,
wortmannin and LY294002, and the SFK inhibitor, PP2, but not
in PP3-treated cells (Fig. 4, A). None of these inhibitors disrupted
the actin cytoskeleton at the concentration tested as judged by the
phalloidin staining pattern in uninfected cells. These results
suggested that both PI3K and c-Src are involved in regulating
actin polymerization during spore entry.
PI3K and SFKs can act in the same signaling pathway or in
independent pathways to transduce signals to downstream
effectors leading to the activation of actin cytoskeleton. Therefore,
we investigated the connection between PI3K and c-Src in
mediating spore uptake by epithelial cells. If PI3K and c-Src
function in the same signaling pathway, treating cells with
inhibitors for both PI3K and c-Src simultaneously should have
the same effect on spore internalization as treating cells with
individual inhibitor alone. On the other hand, if they function in
independent pathways, inhibition of both kinases would have a
synergistic effect compared to inhibition of the individual kinase.
The results showed that treatment of A549 cells with both
LY294002 and PP2 caused a similar level of reduction in F-actin
enrichment around spores compared to the reductions seen with
individual inhibitor only (,40% reduction; **, p,0.01) (Fig. 4, A),
suggesting that PI3K and SFKs functioned in the same signaling
pathway for spore internalization.
To further investigate the order of PI3K and c-Src activation in
the signaling cascade, we examined the recruitment of Akt-PH-
GFP upon spore attachment in cells treated with PP2. In PP2
treated cells, the recruitment of Akt-PH-GFP was reduced
(***, p,0.001 compared to the no inhibitor control) to a similar
level as those in cells treated with wortmannin or LY294002 (Fig. 4,
B). Treatment of cells with both PP2 and LY294002 did not cause
any further reduction in Akt-PH-GFP recruitment (,40%,
***, p,0.001) compared to cells treated with the individual
inhibitor (Fig. 4, B). PP3 had no effect on Akt-PH-GFP
recruitment. These results suggest that PI3K likely act downstream
of c-Src in the signaling pathway involved in spore internalization
by epithelial cells.
Figure 4. Src and PI3K act in a linear signaling pathway. A,F -
actin colocalization with spores is reduced in the presence of WM, LY
and PP2. A549 cells were pre-incubated with WM (100 nM), LY (50 mM),
PP2 (10 mM), PP3 (10 mM), LY (50 mM) + PP2 (10 mM) or solvent control
for 1 hr and then incubated with Texas Red-labeled 7702 spores in the
presence of the respective inhibitors for 30 min and then stained for F-
actin. The samples were examined using confocal fluorescence
microscopy. Relative F-actin colocalization is the ratio of spores that
associated with enriched F-actin staining vs. total spores that attached
to the cells, normalized to the solvent control. B,A k t - P H - G F P
recruitment is reduced in the presence of LY and PP2. A549 cells
transfected with Akt-PH-GFP were pre-incubated with LY (50 mM), PP2
(10 mM), PP3 (10 mM), LY (50 mM) + PP2 (10 mM) or solvent control for
1 hr and then incubated with labeled spores in the presence of the
respective inhibitors for 8 min. Relative Akt-PH-GFP recruitment is the
ratio of spores that recruited Akt-PH-GFP vs. total spores that attached
to the cells, normalized to the solvent control. The results are the mean
6 SEM from at least three experiments. ***, p,0.001; **, p,0.01, t test.
doi:10.1371/journal.pone.0011665.g004
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requires Src activity
It was previously shown that B. anthracis could translocate across
an A549 cell barrier without apparent disruption of the barrier
integrity, suggesting that translocation occurred via an intracellu-
lar route [1]. We tested if inhibiting Src activity would reduce
bacterial translocation. A549 cells grown on transwell inserts were
treated with PP2, SU6656, PP3, or no inhibitor. Spores were
added to the apical side of A549 cells and incubated in the
presence of the inhibitor. Significantly less bacteria were recovered
from the bottom chambers of cells treated with PP2 and SU6656
respectively, compared to the control (Fig. 5, A, ***, p,0.001).
PP3, a negative control compound for PP2, did not have any effect
on translocation (Fig. 5, A). The inhibitor treatment did not
compromise the A549 cell barrier integrity as assessed by FITC-
dextran diffusion from the top to the bottom chambers in the
inhibitor-treated and the control wells (Fig. 5, B). To rule out the
possibility that the inhibitors affected vegetative growth of B.
anthracis, which could have resulted in fewer bacteria in the bottom
chambers, we examined the effect of the inhibitors on bacterial
growth in the tissue culture conditions. No difference was observed
(Fig. 5, C). Together, the above results indicate that Src activity is
required for B. anthracis translocation across a barrier of lung
epithelial cells.
Inhibition of Src activity reduces bacterial dissemination
in a mouse model of inhalational anthrax
In pilot experiments, A/J mice were inoculated with ,1–3610
6
spores/mouse by intranasal instillation (i.n.). Bacterial counts in
the spleen were determined at 24, 48 and 72 hr post inoculation.
Few bacteria were found in the spleens at 24 or 48 hr. However,
substantial amounts of bacteria were recovered at 72 hr. We also
found that 72 hr is the approximate median survival time for mice
infected with the indicated spore dose via the i.n. route. To
determine if inhibition of Src activity would affect bacterial
dissemination in vivo, mice were treated with either SU6656
(7.5 mg/g body weight) [24] or an equivalent volume of solvent by
daily i.p. injection as described in Materials and Methods. Mice
were inoculated with spores via the i.n. route and bacterial
dissemination was examined at 72 hr post inoculation. Signifi-
cantly fewer bacteria were recovered from the spleen and blood of
SU6656-treated mice compared to those from the control mice
(*, p,0.05) (Fig. 6, A and B). In contrast, there was no significant
difference in the lung bacterial counts between the treated and the
control groups (Fig. 6, C), suggesting that SU6656 treatment did
not affect bacterial survival in the lung. To further examine
whether the reduction in bacterial burden could be due to non-
specific effects of SU6656, spores were directly injected into the
peritoneum (i.p.) or the tail vein (i.v.) of mice. The appropriate
spore dose and the median survival time for the i.p. and i.v. routes
of infection were determined in pilot experiments. The spleen
bacterial burden in i.p. inoculated mice were essentially the same
between SU6656-treated and the control mice at 72 hr post
inoculation (, median survival time) (Fig. 6, D). For i.v. inoculated
mice, blood were collected at 84 hr post inoculation (, median
survival time) and dilution plated. No difference was observed in
the blood bacterial counts between the treated and the control
groups (Fig. 6, E), suggesting that SU6656 did not affect bacterial
survival or growth in the blood. The effect of the inhibitor on
mouse survival was also tested. The results showed that although
SU6656 treatment did not prevent death, it prolonged mouse
survival time (Fig. 6, F, p,0.05, compared with the control group).
The median survival time was increased by an average of 12 hr
with the inhibitor treatment (84 hr for the treatment group vs.
72 hr for the control group, calculated from 4 independent
experiments with a total of 37 mice per group). In contrast, in i.p.
inoculated mice, there was no difference in the survival curves
between the SU6656-treated and the control groups (Fig. 6, G).
Together these results strongly suggest that Src activity is
important for bacterial dissemination through the respiratory
epithelium and virulence in vivo.
Discussion
The airway and lung epithelium not only functions as a
mechanical barrier to inhaled pathogens but also actively
participates in host immune responses such as pathogen
recognition and production of cytokines, chemokines and anti-
microbial peptides. It is thus an important component in the host
defense system against microbial pathogens. On the other hand, to
establish an inhalational anthrax infection, B. anthracis must breach
the respiratory epithelial barrier. Earlier studies suggested that B.
anthracis spores potentially could use lung epithelial cells in addition
Figure 5. Src activity is required for B. anthracis translocation through an A549 cell barrier. A549 cells grown in transwell inserts were pre-
treated with PP2 (10 mM), PP3 (10 mM), and SU6656 (50 mM) or solvent (Ctrl) for 1 hr. Spores were then added to the top chambers as described in
Materials and Methods. Media was collected from the bottom chambers after 16 hr of incubation. An aliquot of the media was dilution plated to
determine bacterial counts (A). Another aliquot was used to measure fluorescence emission at 520 nm (FITC-dextran) (B). The effect of the inhibitors
on bacterial growth was also determined (C) as described in Materials and Methods. The results shown are mean 6 SEM from at least two
independent experiments. ***, p,0.001, t test.
doi:10.1371/journal.pone.0011665.g005
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[1,4]. The recent finding that lung epithelial cells rather than
macrophages or neutrophils were responsible for the induction of
innate resistance to pulmonary exposure of spores highlighted the
importance of B. anthracis-epithelium interactions in the patho-
genesis of this organism. The report that mice immunized with
inactivated spores were protected by cellular rather than humoral
immunity further emphasized the importance of an intracellular
stage during the establishment of anthrax infections [5]. Although
a fair amount of information is available on spore-macrophage
interactions, there are few previous reports on the molecular
mechanisms underlying the interactions between spores and lung
epithelial cells.
In this study we sought to determine the molecular events
involved in spore entry into lung epithelial cells. The results
indicate that spore uptake by epithelial cells is dependent on the
actin cytoskeleton and a signaling pathway involving Src, PI3K
and Cdc42. Furthermore, we provide evidence that Src activity is
important for B. anthracis translocation through a barrier of lung
epithelial cells in culture as well as dissemination from the lung to
distal organs in mice.
The involvement of the actin cytoskeleton in spore
internalization is supported by three lines of evidence. Uptake
of spores by A549, HeLa and primary hSAECs was virtually
abolished in the presence of cytochalasin D. Local F-actin
enrichment was observed at spore attachment sites, suggesting
a ‘‘zipper’’-like entry mechanism [25]. Furthermore, spore
internalization was specifically inhibited by a DN mutant of
Cdc42, but not by DN mutants of Rac1 or RhoA, suggesting
that Cdc42 is the major Rho-family GTPase regulating the
actin polymerization events during spore entry. The require-
ment for class IA PI3K activities is supported by the following
evidence. Spore internalization was inhibited by two structur-
ally and mechanistically distinct PI3K inhibitors, wortmannin
and LY294002, and by a DN mutant of the p85 regulatory
subunit of class IA PI3K. In addition, Akt-PH-GFP was rapidly
recruited to the spore attachment sites, and the recruitment
was reduced in the presence of wortmannin or LY294002. The
requirement for Src activity is supported by the inhibitory
effects of two distinct SFK inhibitors PP2 and SU6656, and
specific siRNA knockdown of Src.
The results also showed that inhibition of either PI3K or Src
decreased F-actin enrichment around spore attachment sites.
Inhibition of both PI3K and Src did not result in additional
decreases of F-actin enrichment as compared to individual
inhibitor treatment only, suggesting that PI3K and Src are in
the same signaling pathway for spore internalization. In addition,
inhibition of Src activity reduced PI3K recruitment and activation,
suggesting that Src likely acts upstream of PI3K in the signaling
pathway. Based on these results we propose a working model for
the signaling pathway responsible for spore entry into epithelial
cells (Fig. 7).
Figure 6. Src activity is important for bacterial dissemination in vivo. A/J mice were treated with SU6656 (7.5 mg/g body weight) or
equivalent volumes of solvent 24 hr prior to spore inoculation as described in Materials and Methods. A–C , bacterial burden in the spleen (A), blood
(B) and lungs (C) of mice inoculated by intranasal instillation. Each mouse was inoculated with 1 - 3610
6 spores. Organs were harvested at 72 hr post
inoculation, homogenized and plated. The results are combined from 2 – 3 independent experiments with a total of 7–15 mice per treatment group.
D, mice were inoculated with 1610
5 spores/mouse by i.p. injection. Bacterial burden in the spleen was determined at 72 hr post inoculation. The
results are combined from 2 independent experiments with a total of 12 mice per treatment group. E, mice were inoculated with 1610
4 spores/
mouse by injection into the tail vein. Bacterial counts in the blood were determined at 84 hr post inoculation. The results were combined from 2
independent experiments with a total of 13 mice per treatment group. Statistical significance was calculated using t test. *, p,0.05. F, SU6656
treatment improves survival in i.n. inoculated mice. Mice were inoculated with ,8610
6 spores/mouse intranasally (10 mice per group). Statistical
significance was calculated using the Logrank test. Similar trend was observed in three other experiments. G, mice were inoculated with ,1610
5
spores/mouse by i.p. injection. The results are from two experiments with a total of 20 mice per group.
doi:10.1371/journal.pone.0011665.g006
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pathway elucidated here is specifically required for spore entry
into epithelial cells but not macrophages. This is not surprising
considering that the cellular receptors mediating spore entry into
these two types of cells are almost certain to be distinct. Oliva et al.
reported that integrin aMb2 (Mac-1) was the receptor mediating
phagocytosis of wild type spores by macrophages [26]. Since Mac-
1 is not expressed in epithelial cells, a different receptor should be
required for spore uptake by epithelial cells. Studies to identify the
epithelial receptor are currently underway in our laboratory.
The results from the transwell assays indicate that inhibition of
Src-mediated spore entry dramatically reduced B. anthracis
dissemination through epithelial cells. This led us to investigate
if inhibition of Src would have a similar effect on dissemination in
vivo. Although knockout mice are commonly used to examine the
importance of a host factor in pathogenesis, c-src
2/2 mice show a
number of abnormalities such as a small body size, a partial
absence of bone marrow, abnormal decidualization and in some
genetic background post-natal lethality (Jackson Laboratories
http://jaxmice.jax.org). Therefore they were not chosen for this
study due to the consideration that these abnormalities may
complicate the interpretation of results. Instead, we used the SFK
inhibitor SU6656. This inhibitor only inhibits four members of the
SFK family, Src, Fyn, Yes and Lyn and thus is far more selective
than PP1 or PP2, the other two commonly used SFK inhibitors
[27]. The results showed that SU6656 treatment at the indicated
dosage significantly reduced bacterial dissemination from the lung
to the spleen and blood, suggesting that Src activity is important
for bacterial dissemination in vivo. The observation that SU6656
did not significantly affect bacterial counts in the lungs of i.n.
inoculated mice, in the spleen of i.p. inoculated mice, or in the
blood of i.v. inoculated mice suggests that under the experimental
conditions used in these studies SU6656 treatment does not affect
the ability of the host to clear the pathogen, the ability of
phagocytes to the pathogen to lymphoid tissues, or pathgoen
growth in vivo. Thus the reduction of bacterial counts in the spleen
and blood of SU6656-treated, i.n. inoculated mice is likely due to a
disruption in the dissemination process from the lung to other
organs rather than due to non-specific effects of the inhibitor. The
SU6656 treatment did not completely abolish dissemination. This
is likely due to incomplete inhibition of the kinase activity by the
inhibitor and/or dissemination via other routes that do not require
this signaling pathway. The effect of SU6656 treatment on mouse
survival is consistent with its effect on dissemination. At the dose
used, SU6656 significantly improved the survival of i.n. inoculated
mice by prolonging the median survival time, whereas it did not
affect the survival of i.p. inoculated mice. Death was not prevented
since dissemination was not completely blocked. Together these
results provide evidence suggesting Src-dependent spore entry into
epithelial cells is important for dissemination and virulence in vivo.
Combined with the previous finding that lung epithelial cells
rather than macrophages or neutrophils are responsible for
bacterial lysate-induced host resistance to B. anthracis [11], the
data highlights the need for more studies to understand the
molecular details of spore-epithelium interactions and their impact
on bacterial pathogenesis and host defense. It should be noted that
lung epithelial cells may not be the only cell type affected by
SU6656 treatment in vivo. Despite all the control animal
experiments, the possibility that the effect of SU6656 treatment
on dissemination and survival is due to altered activities in other
cell types cannot be excluded. Further tests in mouse models
lacking the specific epithelial receptor will permit more targeted
examination of the complex interplays between the pathogen and
the lung epithelium.
That disruption of SFK activities can impair dissemination of
microbial pathogens was previously described for Streptococcus
pneumoniae, although in a somewhat different context. S. pneumoniae
was shown to migrate across respiratory epithelial cells by
hijacking the host transcytosis pathway for transporting polymeric
immunoglobulin receptor (pIgR) across polarized epithelial cell
[28]. This transcytosis pathway is mediated by the SFK member c-
Yes. In c-yes
2/2 mice, dissemination of S. pneumoniae from the
respiratory system to the blood was delayed compared to that in
the wild-type mice [28]. Our results from the SFK inhibitor
Figure 7. A working model of the mechanism of B. anthracis spore internalization by epithelial cells. B. anthracis spores interact with an
unknown cell surface receptor. The signal is transduced via a pathway including c-Src, class IA PI3K, and the Rho-family GTPase Cdc42. Eventually F-
actin polymerization is activated locally around spore attachment sites, leading to spore internalization.
doi:10.1371/journal.pone.0011665.g007
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inhibiting their entry or passage through epithelial cells. The
results also raised the potential of using SFK inhibitors, or
inhibitors of other host pathways important for the dissemination
of microbial pathogens, as therapeutic agents in conjunction with
antibiotics to treat certain infectious diseases.
Another potential importance of spore entry into lung epithelial
cells is gaining access to an intracellular niche that may allow
persistent colonization of the microbes. B. anthracis spores are
known to persist in the lung for weeks or months [29,30,31], the
basis for the 60-day prolonged antibiotic treatment for patients
exposed to spores. It was shown previously that spores and
vegetative bacilli can survive inside lung epithelial cells for up to
12 hours [1], suggesting that the intracellular environment of lung
epithelial cells can potentially be a site for spore persistence.
However, it is not known in which intracellular compartments
spores and bacilli reside or how long they can remain viable in
those compartments. In macrophages, earlier studies showed that
after phagocytosis spores were trafficked along the endocytic
pathway and eventually were enclosed within LAMP1
+ lysosomal
compartments [32,33]. How long spores can survive or remain as
spores (i.e., not germinate) in the lysosomal compartments of
macrophages remains unclear. The fate of germinated spores and
vegetative bacilli inside macrophages has been controversial. Some
studies showed bacilli replication inside macrophages [32,33]
whereas others indicated efficient killing of vegetative bacilli by
macrophages [7,8]. Therefore it would be interesting to investigate
the intracellular events following spore entry into host cells not
only in the context of microbial passage through host cells but also
persistence within host cells.
Together, the data presented here elucidate a specific signaling
pathway required for B. anthracis spore internalization by epithelial
cells. The pathway includes c-Src, PI3K, Cdc42 and the actin
cytoskeleton. The results also demonstrate that this pathway is
important for B. anthracis translocation through a lung epithelial
barrier in vitro, dissemination from the lung to distal organs, and
virulence in vivo. Further studies to elucidate the epithelial
receptor(s) with which spores interact and the intracellular events
following spore entry will not only be important to the
pathogenesis of this organism but will also reveal host receptors
and signaling pathways that may be used by other respiratory
pathogens to overcome the mucosal barrier.
Materials and Methods
Cell culture, bacterial strain and spore preparation
A549 (a human epithelial cell line derived from lung carcinoma,
ATCC) and HeLa (a human epithelial cell line derived from
cervical cancer cells, ATCC) cells were cultured in F12 and
Dulbecco’s Modified Eagle Media (DMEM), respectively, supple-
mented with 10% fetal bovine serum (FBS). CloneticsH primary
human small airway epithelial cells (hSAECs) (Cambrex) were
maintained at 37uC in a humidified chamber with 5% CO2 in
SABM media supplemented with reagents from the SAGM
SingleQuot kit (Cambrex), following instructions from the
supplier. Murine lung epithelial cells (MLE15) were cultured in
DMEM with 10% FBS [34]. Murine embryonic fibroblasts
(MEFs) from src-/-yes-/-fyn-/- triple knockout mice were obtained
from ATCC and cultured according to instructions from ATCC.
Primary murine peritoneal macrophages from C57BL/6 mice
were kindly provided by Dr. Dekai Zhang, Texas A&M Health
Science Center – IBT, Houston, TX, and were used within 24 hr
of isolation. B. anthracis Sterne strain 7702 was provided by Dr. T.
M. Koehler, UT Health Science Center, Houston, TX. Spores
were prepared from strain 7702 cultured in PA media following a
procedure described previously [1].
Inhibitors and plasmid constructs
Cytochalasin D, wortmannin, LY294002 and SU6656 were
purchased from Sigma. PP2 and PP3 were obtained from
Calbiochem. All inhibitors were dissolved in DMSO to prepare
stock solutions. Plasmids expressing dominant negative p85a (HA-
Dp85a)[ 1 7 ] ,w i l d - t y p ep 8 5 a (HA-p85a) and the vector control (SRa)
were provided by Dr. Lei Wei, Indiana University-Purdue University
Indianapolis, Indianapolis, IN. Dominant negative constructs for
RhoA (HA-T19NRhoA), Rac1 (HA-T17NRac1) and Cdc42 (HA-
T17NCdc42) were purchased from UMR cDNA Resource Center
(www.cdna.org) [14]. Akt-PH-GFP construct (in pEGFP-N1 vector)
was provided by Dr. Tamas Balla, National Institute of Child Health
and Human Development, NIH, Bethesda, MD [19].
Cell transfection
A549 and HeLa cells were transfected with DNA plasmids using
Lipofectamine LTX (Invitrogen) following the instructions from
the supplier. Briefly, the cells were seeded in 24-well plates at a
density of 40,000 cells/well 24 hours prior to transfection. DNA
(0.25–0.5 mg) and 0.5 ml Plus Reagent (Invitrogen) were mixed and
incubated in 100 ml Opti-MEM I medium (Invitrogen) for 10 min,
followed by addition of 1–2 ml of LTX and incubated for 25 min.
The mixture was then added to the cells.
Lipofectamine RNAiMAX (Invitrogen) was used to transfect
siRNAs into A549 cells following the instructions from the supplier.
Briefly, 1 ml RNAiMAX and 100 ml opti-MEM I were mixed with
specific siRNAs against c-Src, c-Yes and Fyn (c-Src and Fyn siRNA
were from Santa Cruz Biotechnology whereas c-Yes siRNA and the
Allstars negative control siRNA were from Qiagen) and incubated
for 12 min. The mixture was then added to each well of a 24-well
plate to give a final siRNA concentration of 50 nM.
Western Blot
Cells were harvested 24 hours post DNA plasmid transfection
and 48 hours post siRNA transfection, washed and lysed with
RIPA buffer (50 mM Tris-HCl pH 7.4, 1% NP-40, 0.25% Na-
deoxycholate, 150 mM NaCl, 1 mM EDTA) containing Com-
plete Mini protease inhibitors (Roche). Cell lysates were then
mixed with an equal volume of 26 Laemmli sample buffer
(BioRad) containing 5% b-mercaptoethanol and boiled at 100uC
for 5 min. Samples were subjected to 4%/12% SDS-polyacryl-
amide gel electrophoresis, and then transferred to a PVDF
membrane (Millipore). The membrane was blocked with 5% non-
fat milk in a solution of 100 mM Tris-Cl pH 8.0, 0.9% NaCl, and
0.1% Tween20 (TBST), and then incubated with the appropriate
primary and secondary antibodies. For detection, the membrane
was incubated with a chemiluminescent substrate HyGLO HRP
(Denville) for 1 min at room temperature, exposed to X-ray films
(Kodak) and developed in a film processor (Konica SRX-101A).
The different primary antibodies were anti-HA (Millipore)
(1:1000 dilution in TBST containing 5% milk), anti-Src (Millipore,
1:1000), anti-Yes (BD Biosciences, 1:1000), anti-Fyn (BD Biosci-
ences, 1:1000) and anti-actin (Millipore) (1:6000) antibodies. The
secondary antibodies were HRP-conjugated goat anti-mouse
antibodies (Millipore, 1:3000) and goat anti-rabbit antibodies
(BioRad, 1:6000).
Gentamicin protection assay
This was performed as described previously [1] with slight
modifications. Briefly, cells grown in 24-well tissue culture plates
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infection (MOI) of ,1. The assays were performed in DMEM
containing 10% FBS (DMEM/FBS). A549 and HeLa cells were
incubated with spores for 1 and 2 hr, respectively. Unbound
spores were then removed by washing with PBS. To enumerate
associated bacteria (extracelluar adhered and intracellular), cells
were then lysed and dilution plated. To enumerate intracellular
bacteria, after washing with PBS, cells were further incubated in
media containing gentamicin (100 mg/ml) for 1 hour, washed,
lysed and dilution plated.
To examine the effect of inhibitors (cytochalasin D, wortman-
nin, LY294002, PP2, PP3 and SU6656), cells were pre-incubated
with the appropriate inhibitor for 1 hr and then incubated with
spores in the presence of the inhibitor. For controls, the same
amount of the inhibitor solvent was added.
For cells transfected with DNA plasmids, gentamicin protection
assays were performed 24 hours post transfection. For cells
transfected with siRNA, assays were performed 48 hours post
transfection.
Examine spore adherence and internalization using
fluorescence microscopy
This was performed as described previously [1] with slight
modifications. A549, HeLa or hSAECs grown on glass coverslips
in 24-well plates were incubated with FITC- and biotin-labeled B.
anthracis spores (MOI of ,4) in the presence of 2.5 mM D-alanine,
a germination inhibitor, for 1 hr for A549 and 2 hr for HeLa and
hSAECs. For assays containing inhibitors (cytochalasin D,
wortmannin, LY294002, PP2 and PP3), cells were pre-incubated
with the respective inhibitor for 1 hr and then incubated with the
same amount of labeled spores in the presence of the inhibitors as
in the presence of solvent control. Cells were then washed, fixed
without permeablization, blocked and incubated with streptavidin
– Alexa Fluor 647 (Molecular Probes). After washing, the
coverslips were mounted using Fluorsave (Calbiochem) and
viewed using a Zeiss Axiovert 135 microscope as previously
described [1]. In each experiment, ,1000 spores in at least 50
fields were counted per test condition.
Spore labeling efficiency was monitored by performing the same
procedure as described above but in the absence of cells [1].
Briefly, labeled spores were allowed to attach to poly L-lysine
(Sigma) coated coverslips and incubated in DMEM/FBS under
cell culture conditions in the presence of 2.5 mM D-alanine. The
coverslips were then processed exactly the same way as the
coverslips containing cells incubated with spores as described
above. Approximately 200 spores were examined for each
experiment and the labeling was proved to be efficient.
Colocalization of F-actin and PI3K with spores
A549 cells grown on coverslips were serum starved overnight
and then incubated with Texas Red (Molecular Probes)-labeled
spores in DMEM. To examine F-actin colocalization, cells were
incubated with labeled spores for 30 min, washed, fixed with 2%
paraformaldehyde, and blocked in PBS containing 10% FBS. The
cells were then stained with Phalloidin-Alexa Fluor 488 (1:250 in
PBS/FBS, Molecular Probes). To examine recruitment and
activation of PI3K, cells were transfected with the Akt-PH-GFP
plasmid. 24 hours post-transfection, cells were serum starved and
then incubated with labeled spores for 5–15 minutes. Cells were
then washed and fixed. The coverslips were mounted and viewed
in a Zeiss LSM 510 confocal laser scanning fluorescence
microscope with LSM 4.0 software (Zeiss).
For assays involving inhibitors, cells were pre-incubated with the
appropriate inhibitor for 1 hr and then incubated with labeled
spores in the presence of the inhibitors. In each experiment, ,100
spores were counted per test condition.
Cell viability and spore viability
The effect of the inhibitors (cytochalasin D, wortmannin,
LY294002, PP2 and PP3) on cell viability was monitored by
incubating cells with each inhibitor and the solvent control for the
same length of time under the same conditions as in cell infection
assays. The cells were then examined by trypan blue exclusion in a
haemacytometer. The effect of transfection with various dominant
negative constructs on cell viability was also monitored using
trypan blue exclusion 24 hours post-transfection. To determine
the effect of inhibitors on spore viability, 7702 spores were
incubated in the presence of an inhibitor or the solvent control for
the same length of time under the same conditions as in cell
infection assays and then dilution plated. The number of colony
forming units (cfu) from inhibitor-treated spore samples was then
compared with that from the control.
Translocation assays
Translocation assays were performed based on a procedure
described previously [1] with modifications. Briefly, A549 cells
were grown on collagen-coated polyester TranswellH inserts
(Corning) for 13–16 days. DMEM/FBS containing B. anthracis
7702 spores (MOI ,4), 0.1 mM FITC-dextran (Sigma) and
2.5 mM D-alanine were added to the upper chambers and
incubated for 16 hours. An aliquot of the bottom chamber media
was plated for bacterial counts and another was used to measure
fluorescence emission at 520 nm in a LS 50B Luminescence
Spectrometer (Perkin Elmer) to monitor the presence of FITC-
dextran. The experiment was performed in triplicates and
repeated at least twice.
To examine the effect of SFK inhibitors on translocation, cells
were pre-treated with PP2 (10 mM), PP3 (10 mM), SU6656
(50 mM), or solvent control for 1 hour. Translocation assays were
then carried out in the presence of the inhibitors. The effect of the
inhibitors on bacterial growth was examined by incubating 7702
in DMEM/FBS containing the various inhibitors or the solvent at
37uC in a humidified chamber with 5% CO2. Samples were
collected every hour and dilution plated to determine bacterial
counts.
Mouse infections
All animal experiments were carried out according to
procedures approved by the Institutional Animal Care and Use
Committee at the Texas A&M Health Science Center, Institute of
Biosciences and Technology (IBT) (protocol #08032). A/J mice
were originally purchased from the Jackson Laboratory and
maintained in the IBT animal facility as approved in the protocol.
Mice were 5–8 weeks old when experiments were initiated. For
intranasal inoculation (i.n.) of spores, 20 ml of a spore suspension
were deposited onto the nares of anesthetized mice to be inhaled.
For intravenous and intraperitoneal inoculation, 200 and 100 mlo f
a spore suspension were injected into the tail vein and the
peritoneal cavity of mice, respectively. For inhibitor treatment,
approximately 100 ml of SU6656 (the final volume is adjusted to
reach a dosage of 7.5 mg/g body weight) or solvent were
administered by i.p. injection every 24 hours starting from
24 hours prior to spore inoculation and ending at 48 hours post
inoculation. Median survival time (the median time point at which
50% of mice survive) was calculated using the survival analysis tool
in the GraphPad Prism 4 program. To examine dissemination,
mice were sacrificed, lungs and spleens collected, homogenized
and plated to determine bacterial counts. Blood samples were also
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blood. Mice were monitored twice daily for the survival studies.
Statistical analysis
The Logrank test was used to evaluate the statistical significance
in mouse survival studies. Student’s t-test was used to calculate
statistical significance in all the other data. The GraphPad Prism 4
software was used for these analyses.
Supporting Information
Figure S1 PI3K activity is required for B. anthracis spore
internalization by HeLa cells. The experiments were performed
as described in Figure 2 legend. A, spore internalization by HeLa
cells was inhibited by WM (50 nM) and LY (50 mM). B, spore
adherence to HeLa cells was not affected by WM or LY
significantly. C, western blot analysis of the expression of mutant
p85a and p85a in transfected HeLa cells. D, spore internalization
by HeLa cells was inhibited by the expression of mutant p85a.E ,
spore adherence to HeLa cells was not affected by mutant p85a.
Found at: doi:10.1371/journal.pone.0011665.s001 (0.07 MB
PDF)
Figure S2 Src activity is specifically required for spore entry into
epithelial cells. A, PP2 (10 mM) was added to cells prior to and
during the 1 hour incubation with spores. Spore uptake was
assessed following the procedures described in the legends for
Figures 1 and 2. Relative uptake was calculated as the percentage
of uptake in the presence of PP2 normalized to the no inhibitor
control for each type of cells. The results are compiled from at
least 3 independent experiments. A549, human alveolar epithelial
cell line; HeLa, human cervical epithelial cell line; hSAEC,
primary human small airway epithelial cells (Cambrex); MLE,
murine lung epithelial cell line MLE15; RAW, murine macro-
phage cell line RAW264.7; PPM, primary peritoneal macrophages
from C57BL/6 mice. B, phagocytosis of spores by RAW264.7 was
inhibited by LY294002 (LY). RAW264.7 were pre-treated with
LY (50 mM) for 1 hr. Spore phagocytosis was performed using
gentamicin protection assays described in Materials and Methods.
The phagocytosis assays were performed in the presence of the
inhibitor.
Found at: doi:10.1371/journal.pone.0011665.s002 (0.04 MB
PDF)
Acknowledgments
We are grateful to Lei Wei, IUPUI, Indianapolis, IN, Tamas Balla,
NICHD, NIH, Bethesda, MD, Mingyao Liu and Dekai Zhang,
TAMHSC-IBT for their generous help in providing constructs, primary
macrophages and technical advice.
Author Contributions
Conceived and designed the experiments: QX SAJ BHR YX. Performed
the experiments: QX SAJ CG ES QL RV. Analyzed the data: QX SAJ
YX. Wrote the paper: QX YX.
References
1. Russell BH, Vasan R, Keene DR, Koehler TM, Xu Y (2008) Potential
dissemination of Bacillus anthracis utilizing human lung epithelial cells. Cell
Microbiol 10: 945–957.
2. Cleret A, Quesnel-Hellmann A, Vallon-Eberhard A, Verrier B, Jung S, et al.
(2007) Lung dendritic cells rapidly mediate anthrax spore entry through the
pulmonary route. J Immunol 178: 7994–8001.
3. Guidi-Rontani C (2002) The alveolar macrophage: the Trojan horse of Bacillus
anthracis. Trends Microbiol 10: 405–409.
4. Russell BH, Liu Q, Jenkins SA, Tuvim MJ, Dickey BF, et al. (2008) In vivo
demonstration and quantification of intracellular Bacillus anthracis in lung
epithelial cells. Infect Immun 76: 3975–3983.
5. Glomski IJ, Corre JP, Mock M, Goossens PL (2007) Cutting Edge: IFN-gamma-
producing CD4 T lymphocytes mediate spore-induced immunity to capsulated
Bacillus anthracis. J Immunol 178: 2646–2650.
6. Russell BH, Vasan R, Keene DR, Xu Y (2007) Bacillus anthracis internalization
by human fibroblasts and epithelial cells. Cell Microbiol 9: 1262–1274.
7. Hu H, Sa Q, Koehler TM, Aronson AI, Zhou D (2006) Inactivation of Bacillus
anthracis spores in murine primary macrophages. Cell Microbiol 8: 1634–1642.
8. Kang TJ, Fenton MJ, Weiner MA, Hibbs S, Basu S, et al. (2005) Murine
macrophages kill the vegetative form of Bacillus anthracis. Infect Immun 73:
7495–7501.
9. Welkos S, Friedlander A, Weeks S, Little S, Mendelson I (2002) In-vitro
characterization of the phagocytosis and fate of anthrax spores in macrophage
and the effects of anti-PA antibody. J Med Microbiol 51: 821–831.
10. Chakrabarty K, Wu W, Booth JL, Duggan ES, Nagle NN, et al. (2007) Human
lung innate immune response to Bacillus anthracis spore infection. Infect Immun
75: 3729–3738.
11. Evans SE, Scott BL, Clement CG, Larson DT, Kontoyiannis D, et al. (2009)
Stimulated innate resistance of lung epithelium protects mice broadly against
bacteria and fungi. Am J Respir Cell Mol Biol 42: 40–50.
12. Jewett TJ, Fischer ER, Mead DJ, Hackstadt T (2006) Chlamydial TARP is a
bacterial nucleator of actin. Proc Natl Acad Sci U S A 103: 15599–15604.
13. Jaffe AB, Hall A (2005) Rho GTPases: biochemistry and biology. Annu Rev Cell
Dev Biol 21: 247–269.
14. Feig LA (1999) Tools of the trade: use of dominant-inhibitory mutants of Ras-
family GTPases. Nat Cell Biol 1: E25–27.
15. Walker EH, Pacold ME, Perisic O, Stephens L, Hawkins PT, et al. (2000)
Structural determinants of phosphoinositide 3-kinase inhibition by wortmannin,
LY294002, quercetin, myricetin, and staurosporine. Mol Cell 6: 909–919.
16. Vanhaesebroeck B, Waterfield MD (1999) Signaling by distinct classes of
phosphoinositide 3-kinases. Exp Cell Res 253: 239–254.
17. Hara K, Yonezawa K, Sakaue H, Ando A, Kotani K, et al. (1994) 1-
Phosphatidylinositol 3-kinase activity is required for insulin-stimulated glucose
transport but not for RAS activation in CHO cells. Proc Natl Acad Sci U S A
91: 7415–7419.
18. Hawkins PT, Anderson KE, Davidson K, Stephens LR (2006) Signalling
through Class I PI3Ks in mammalian cells. Biochem Soc Trans 34: 647–662.
19. Varnai P, Balla T (2006) Live cell imaging of phosphoinositide dynamics with
fluorescent protein domains. Biochim Biophys Acta 1761: 957–967.
20. Varnai P, Bondeva T, Tamas P, Toth B, Buday L, et al. (2005) Selective cellular
effects of overexpressed pleckstrin-homology domains that recognize
PtdIns(3,4,5)P3 suggest their interaction with protein binding partners. J Cell
Sci 118: 4879–4888.
21. Tanaka M, Konishi H, Touhara K, Sakane F, Hirata M, et al. (1999)
Identification of myosin II as a binding protein to the PH domain of protein
kinase B. Biochem Biophys Res Commun 255: 169–174.
22. Oliva C, Turnbough CL, Jr., Kearney JF (2009) CD14-Mac-1 interactions in
Bacillus anthracis spore internalization by macrophages. Proc Natl Acad
Sci U S A 106: 13957–13962.
23. Thomas SM, Brugge JS (1997) Cellular functions regulated by Src family
kinases. Annu Rev Cell Dev Biol 13: 513–609.
24. Severgnini M, Takahashi S, Tu P, Perides G, Homer RJ, et al. (2005) Inhibition
of the Src and Jak kinases protects against lipopolysaccharide-induced acute lung
injury. Am J Respir Crit Care Med 171: 858–867.
25. Cossart P, Sansonetti PJ (2004) Bacterial invasion: the paradigms of
enteroinvasive pathogens. Science 304: 242–248.
26. Oliva CR, Swiecki MK, Griguer CE, Lisanby MW, Bullard DC, et al. (2008)
The integrin Mac-1 (CR3) mediates internalization and directs Bacillus anthracis
spores into professional phagocytes. Proc Natl Acad Sci U S A 105: 1261–1266.
27. Blake RA, Broome MA, Liu X, Wu J, Gishizky M, et al. (2000) SU6656, a
selective src family kinase inhibitor, used to probe growth factor signaling. Mol
Cell Biol 20: 9018–9027.
28. Zhang JR, Mostov KE, Lamm ME, Nanno M, Shimida S, et al. (2000) The
polymeric immunoglobulin receptor translocates pneumococci across human
nasopharyngeal epithelial cells. Cell 102: 827–837.
29. Glassman HN (1966) Discussion. Bacteriol Rev 30: 657–659.
30. Henderson DW, Peacock S, Belton FC (1956) Observations on the prophylaxis
of experimental pulmonary anthrax in the monkey. J Hyg 54: 28–36.
31. Vietri NJ, Purcell BK, Lawler JV, Leffel EK, Rico P, et al. (2006) Short-course
postexposure antibiotic prophylaxis combined with vaccination protects against
experimental inhalational anthrax. Proc Natl Acad Sci U S A 103: 7813–7816.
32. Dixon TC, Fadl AA, Koehler TM, Swanson JA, Hanna PC (2000) Early Bacillus
anthracis-macrophage interactions: intracellular survival and escape. Cell
Microbiol 2: 453–463.
33. Guidi-Rontani C, Levy M, Ohayon H, Mock M (2001) The fate of germinated
Bacillus anthracis spores in primary murine macrophages. Mol Microbiol 42:
931–938.
34. Barrett EG, Johnston C, Oberdorster G, Finkelstein JN (1998) Silica-induced
chemokine expression in alveolar type II cells is mediated by TNF-alpha.
Am J Physiol 275: L1110–1119.
Entry of B. anthracis Spores
PLoS ONE | www.plosone.org 12 July 2010 | Volume 5 | Issue 7 | e11665